Wells Fargo analyst Connor Siversky upgraded Sabra Health Care to Equal Weight from Underweight with a price target of $15, up from $13.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SBRA:
- 2 Big Dividend Stocks Offering up to 8% Yield; Bank of America Says ‘Buy’
- BofA upgrades two skilled nursing REITs, downgrades three net lease REITs
- Sabra Health Care upgraded to Buy from Neutral at BofA
- Sabra Health Care initiated with an Outperform at Wedbush
- Sabra Health Care price target raised to $15 from $13 at Truist
